A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
Assess the safety, tolerability and pharmacokinetics of multiple doses of 10, 20, 30, and 40
mg of Hydrocodone Bitartrate Extended Release (HC-ER)capsules taken with food at steady
state, in subjects with chronic, moderate to severe osteoarthritis (OA) pain.